LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, Supply Disruption — Medaus, Inc. (Moderate Risk —
LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, Supply Disruption — Medaus, Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG,; Manufacturer: Medau
| Drug name | LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, |
|---|---|
| Manufacturer | Medaus, Inc. |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1210-2016 |
| Initiation date | 20160513 |
| Quantity affected | 14000 mL in Vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →